The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Tissue inhibitor of metalloproteinases‐2 inhibits bFGF‐induced human microvascular endothelial cell proliferation
Abstract
Tissue inhibitor of metalloproteinase‐2 (TIMP‐2), a protease inhibitor that binds to the latent and active forms of 72 kDa type IV collagenase (gelatinase A), was found to inhibit the in vitro proliferation of human microvascular endothelial (HME) cells stimulated with bFGF and 5% serum. The maximal inhibitory effect of TIMP‐2 on incorporation of 3 H‐thymidine was evident 24 hours after bFGF stimulation of these cells and ranged between 45 and 60%. The half‐maximal effective concentration of TIMP‐2 was 107 ± 12 nM (S.D.). In contrast, TIMP‐1 was not found to slow the growth of HME cells. The inhibition of cell proliferation observed with TIMP‐2 was not mimicked by addition to the culture medium of BB94, a general matrix metalloproteinase inhibitor, nor antibodies to the 72 kDa type IV collagenase. In addition to growth, two other cell functions associated with the angiogenic process were tested for sensitivity to TIMP‐2. Cell adhesion to tissue culture platic was slightly stimulated by TIMP‐2, and cell migration was inhibited with short‐term exposure to TIMP‐2, but neither process was affected by longer‐term exposure. The ability of TIMP‐2 to inhibit cultured endothelial cell proliferation independent of protease inhibitory activity suggests that TIMP‐2 may have additional actions which may limit neovascularization associated with solid tumor growth and metastasis in vivo. © 1993 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler-Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,720
Self-citationWilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., & Goldberg, G. I. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71480-4 · Cited by 1,109
Tissue Inhibitor of Metalloproteinase (TIMP-2)
Stetler-Stevenson, W. G., Krutzsch, H. C., & Liotta, L. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71503-2 · Cited by 895
Self-citationTumor invasion through the human amniotic membrane: Requirement for a proteinase cascade
Mignatti, P., Robbins, E., & Rifkin, D. B. (1986) · Cell · doi:10.1016/0092-8674(86)90613-6 · Cited by 746
Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., & Iwata, K. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80015-9 · Cited by 695
Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J. R., Murphy, G., & Reynolds, J. J. (1985) · Nature · doi:10.1038/318066a0 · Cited by 689
Goldberg, G. I., Marmer, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S., & He, C. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8207 · Cited by 586
Herron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J., & Werb, Z. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35860-x · Cited by 525
Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T., & Marmer, B. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42873-6 · Cited by 515
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Angiogenesis and Tumor Metastasis
Zetter, B. R. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.407 · Cited by 1,015
Matrix metalloproteinases and angiogenesis
Rundhaug, J. E. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00355.x · Cited by 960
Biological Roles of Fibroblast Growth Factor-2*
Bikfalvi, A., Klein, S., Pintucci, G., & Rifkin, D. B. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0292 · Cited by 959
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Self-citationMatrix metalloproteinases: multifunctional contributors to tumor progression
McCawley, L. J., & Matrisian, L. M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01686-5 · Cited by 643
Curry, T. E., & Osteen, K. G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0005 · Cited by 609
Lambert, E., Dassé, E., Haye, B., & Petitfrère, E. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.008 · Cited by 541
Ovulation: Parallels With Inflammatory Processes
Duffy, D. M., Ko, C., Jo, M., Brannstrom, M., & Curry, T. E. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00075 · Cited by 513
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60862-3 · Cited by 510
TIMP-2 Mediated Inhibition of Angiogenesis
Seo, D.-W., Li, H., Guedez, L., Wingfield, P. T., Diaz, T., Salloum, R., Wei, B.-Y., & Stetler-Stevenson, W. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00551-8 · Cited by 508
Self-citationComplex roles of tissue inhibitors of metalloproteinases in cancer
Jiang, Y., Goldberg, I. D., & Shi, Y. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205291 · Cited by 507
Stetler-Stevenson, W. G. (2008) · Science Signaling · doi:10.1126/scisignal.127re6 · Cited by 489
Self-citationBaker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Rini, B. I., & Small, E. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.186 · Cited by 408
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
Fang, J., Shing, Y., Wiederschain, D., Yan, L., Butterfield, C., Jackson, G., Harper, J., Tamvakopoulos, G., & Moses, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3884 · Cited by 393
Ray, J., & Stetler-Stevenson, W. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07112062 · Cited by 359
Self-citationHuang, S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1134 · Cited by 349
Complex role of matrix metalloproteinases in angiogenesis
Sang, Q. X. A. (1998) · Cell Research · doi:10.1038/cr.1998.17 · Cited by 332
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert, O. V., Ward, W. F., Lingen, M. W., Chesler, L., Solt, D. B., Johnson, M. D., Molteni, A., Polverini, P. J., & Bouck, N. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118838 · Cited by 323
Angiogenesis inhibition: A review
Auerbach, W., & Auerbach, R. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90027-2 · Cited by 321
Fang, J.-H., Zhou, H.-C., Zeng, C., Yang, J., Liu, Y., Huang, X., Zhang, J.-P., Guan, X.-Y., & Zhuang, S.-M. (2011) · Hepatology · doi:10.1002/hep.24577 · Cited by 307
Zempo, N., Koyama, N., Kenagy, R. D., Lea, H. J., & Clowes, A. W. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.1.28 · Cited by 300
The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors
Moses, M. A. (1997) · STEM CELLS · doi:10.1002/stem.150180 · Cited by 298
Sieczkiewicz, G. J., Hussain, M., & Kohn, E. C. (2002) · Ovarian Cancer · doi:10.1007/978-1-4757-3587-1_17 · Cited by 295
Mechanism and its regulation of tumor-induced angiogenesis
Gupta, M. K. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i6.1144 · Cited by 294
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
Johnson, M. D., Kim, H. C., Chesler, L., Tsao‐Wu, G., Polverini, P. J., & Bouck, N. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041600122 · Cited by 288
Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G., & Albini, A. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980119)75:2<246::aid-ijc13>3.0.co;2-b · Cited by 273
Self-citationBullen, E. C., Longaker, M. T., Updike, D. L., Benton, R., Ladin, D., Hou, Z., & Howard, E. W. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12612786 · Cited by 271
Zucker, S., Mirza, H., Conner, C. E., Lorenz, A. F., Drews, M. H., Bahou, W. F., & Jesty, J. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980302)75:5<780::aid-ijc19>3.0.co;2-a · Cited by 270
Lin, S.-S., Lai, K.-C., Hsu, S.-C., Yang, J.-S., Kuo, C.-L., Lin, J.-P., Ma, Y.-S., Wu, C.-C., & Chung, J.-G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.037 · Cited by 254
Molecular Genetics of Human Retinal Disease
Rattner, A., Sun, H., & Nathans, J. (1999) · Annual Review of Genetics · doi:10.1146/annurev.genet.33.1.89 · Cited by 228
Metadata
- Authors
- Murphy, A. N., Unsworth, E. J., & Stetler‐Stevenson, W. G.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 1993-11
- Volume
- 157
- Issue
- 2
- Pages
- 351-358
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2064623632
- Cited by
- 351
- References
- 40
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.